Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...

Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and sometimes dangerous source of food poisoning. Moderna’s ...

Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna dosed its first patient in a global phase 3 clinical trial (usually the last test before seeking regulatory approval) in September of last year. Fink said that testing is expected to ...

Since 2023, Moderna has been working to create a "pandemic influenza ... On Thursday, the CDC issued an alert urging hospitals to speed up efforts to test people who they suspect have an infection.

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in record time and quickly generating blockbuster revenue from it.

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 clinical trials to test the vaccine in a larger group of people after receiving ...